Article Details

Bicara Therapeutics: Clinical-Stage Biotechnology Company Raises Oversubscribed $165 ...

Retrieved on: 2023-12-20 19:32:34

Tags for this article:

Click the tags to see associated articles and topics

Bicara Therapeutics: Clinical-Stage Biotechnology Company Raises Oversubscribed $165 .... View article details on hiswai:

Excerpt

Bicara Therapeutics - a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo